SCHEMBL30934698

SCHEMBL30934698

CN1CCN(Cc2cc(C(=O)O)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDR1 Q08345 9/20 0.52
USP2 O75604 5/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
DDR2 Q16832 7/20 0.49
NTRK1 P04629 1/20 0.49
NTRK3 Q16288 1/20 0.49
NTRK2 Q16620 1/20 0.49
TSHR P16473 2/20 0.47
CYP2D6 P10635 1/20 0.47
CHKA P35790 1/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
ABL1 P00519 3/20 0.47
BCR P11274 2/20 0.47
HPGD P15428 1/20 0.46
SIGMAR1 Q99720 1/20 0.45
CYP3A4 P08684 1/20 0.45
HIF1A Q16665 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15846718 1.00 DDR1 (0.52) DDR1USP2CYP1A2CYP2C19DDR2
SCHEMBL29129019 0.99 DDR1 (0.52) DDR1USP2CYP1A2CYP2C19DDR2
Lithium SCHEMBL30697091 0.99 DDR1 (0.52) DDR1USP2CYP1A2CYP2C19DDR2
SCHEMBL23795672 0.89 USP2 (0.50) DDR1USP2CYP1A2CYP2C19DDR2
SCHEMBL30211921 0.88 DDR1 (0.52) DDR1USP2CYP1A2CYP2C19DDR2
SCHEMBL4949624 0.88 ALDH1A1 (0.55) DDR1DDR2TSHRCYP2D6ALDH1A1
Lithium Ion SCHEMBL29968172 0.87 DDR1 (0.51) DDR1USP2CYP1A2CYP2C19DDR2
Lithium Ion SCHEMBL25341441 0.87 DDR1 (0.51) DDR1USP2CYP1A2CYP2C19DDR2
SCHEMBL30339886 0.86 NOTUM (0.58) DDR1USP2DDR2NTRK1NTRK3
SCHEMBL24071005 0.86 CYP2D6 (0.53) DDR1USP2CYP1A2CYP2C19DDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240190847-A1 INDOLINE DERIVATIVES AS DDR1 AND DDR2 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240190847-A1 INDOLINE DERIVATIVES AS DDR1 AND DDR2 INHIBITORS DDR1, DDR2, DDRGK1 DDR1 1/4885USP2 2486/4885CYP1A2 3511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.